These fascinating science facts prove that reality is often stranger—and a lot more interesting—than fiction These ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025. Regulatory path for VAR 200's ...

Full-body scans are making headlines for potentially catching diseases early, but some doctors urge caution. Here's what you ...

One of the main arguments made for bodyoids is that they could provide spare human organs. There’s a huge shortage of organs ...